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Abstract
Background: Studies from European and non-European countries have shown that migrants utilize cervical cancer
screening less often than non-migrants. Findings from Germany are inconsistent. This can be explained by several
limitations of existing investigations, comprising residual confounding and data which is restricted to only some
regions of the country. Using data from a large-scale and nationwide population survey and applying the Andersen
Model of Health Services Use as the theoretical framework, the aim of the present study was to examine the role
that different predisposing, enabling and need factors have for the participation of migrant and non-migrant
women in cervical cancer screening in Germany.
Methods: We used data from the ‘German Health Update 2014/2015’ survey on n = 12,064 women ≥20 years of
age. The outcome of interest was the participation in cancer screening (at least once in lifetime vs. no
participation). The outcome was compared between the three population groups of non-migrants, migrants from
EU countries and migrants from non-EU countries. We employed multivariable logistic regression to examine the
role of predisposing, enabling and need factors.
Results: Non-EU and EU migrant women reported a lower utilization of cervical cancer screening (50.1 and 52.7%,
respectively) than non-migrant women (57.2%). The differences also remained evident after adjustment for
predisposing, enabling and need factors. The respective adjusted odds ratios (OR) for non-EU and EU migrants were
OR = 0.67 (95%-CI = 0.55–0.81) and OR = 0.80 (95%-CI = 0.66–0.97), respectively. Differences between migrants and
non-migrants were particularly pronounced for younger age groups. Self-rated health was associated with
participation in screening only in non-migrants, with a poorer health being indicative of a low participation in
cancer screening.
Conclusions: The disparities identified are in line with findings from studies conducted in other countries and are
indicative of different obstacles this population group encounters in the health system. Implementing patient-
oriented health care through diversity-sensitive health services is necessary to support informed decision-making.
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Background
Cervical cancer is the seventh most frequent type of in-
cident cancer among women in Europe [1]. Unlike other,
more prevalent, types of cancer, such as carcinoma of
the lung, effective screening by means of the Papanico-
laou (Pap) smear test is available, which has shown to
reduce cervical cancer incidence by 60 to 90% and cer-
vical cancer mortality by up to 90% [2]. Given its effect-
iveness, regular Pap smear testing is recommended by
the World Health Organization [3], the European Union
[4] and different national bodies for women from the
age of 20 or 25 years up to the age of 65 years or older.
Non-utilization of cancer screening among women
and men is associated with lower socioeconomic status
[5–7] as well as with other determinants such as poor
knowledge about cancer prevention [8] and poor self-
rated health [7]. Disparities are particularly pronounced
for migrant communities, which constitute increasingly
large proportions in many European countries [9]. Simi-
lar to breast cancer screening [10–12], many studies
conducted in Europe have shown that migrant women
participate in cervical cancer screening less frequently
than the respective majority populations [13–17]. Com-
parable findings were reported from other regions of the
world such as the United States [18], Canada [19] and
Australia [20]. By means of multivariable analyses, all of
these studies also showed that differences between mi-
grant and non-migrant females with respect to the
utilization of cervical cancer screening are only partially
attributable to the influence of demographic and socio-
economic factors. In addition, qualitative studies have
revealed that migrants encounter different types of bar-
riers in the health care system, such as poor language
proficiency and needs and expectations not sufficiently
accounted for by health care providers, contribute to this
differential [6, 21].
In Germany, around one quarter of the population are
migrants, comprising individuals who themselves or
whose parents immigrated to the country after 1949
[22]. Annual Pap smears are recommended for women
who are 20 years of age or older [23]. Same as many
other types of prevention measures and health care in
general, participation in regular Pap smears is covered
by individuals’ social insurance and is therefore free of
charge for all women, including migrants with a resi-
dence status (refugees and asylum seekers without a resi-
dence status are only entitled to a limited set of services
[24]). Studies show that migrants in Germany – similar
to migrants in other European countries – utilize pre-
ventive services less frequently than the majority popula-
tion [25]. In terms of cancer screening, however, results
are inconsistent. For example, while some studies re-
ported higher rates of participation in breast cancer
screening [26], others showed no differences [27] or
considerably lower utilization rates [28]. Little is known
about the uptake of cervical cancer screening. One
register-based study in the federal state of North Rhine-
Westphalia showed lower odds for regular screening in
different groups of migrants as compared to the majority
population [27]. Another study, using data from a large
health insurance organization, revealed slightly higher
odds of participation for migrants as compared to the
majority population [29]. Both studies are limited since
they only focus on selected regions in Germany. The
available information, based on administrative data, was
also limited and a comprehensive framework such as the
Andersen Model of Health Services Use [30] could not
be used to examine disparities potentially resulting in re-
sidual confounding. Overall, little is known about which
demographic, social, behavioral and health-related fac-
tors influence the decision of migrant women to utilize
cancer screening and whether these factors differ from
those in non-migrant women. By means of data from a
large-scale and nationwide population survey and apply-
ing the Andersen Model of Health Services Use as the
theoretical framework, the aim of the present study was
to examine the role these factors have for the participa-
tion in cervical cancer screening among migrant and
non-migrant women in Germany. Insights gained can
contribute to inform the implementation of diversity-
sensitive services in Germany and other countries which
aim to reduce disparities in access to cancer prevention.
Methods
Data
The analysis uses data from the ‘German Health Update
2014/2015’, a cross-sectional survey conducted by the
Robert Koch-Institute, a research body of the German
Federal Ministry of Health [31], between November
2014 and July 2015. Data was collected by means of a
standardized self-administered online or postal question-
naire depending on the preference of the respondents.
The two-stage cluster sample comprised a total of 24,
016 male and female individuals aged 18 years or older
who lived in private households and who were registered
in population registers with their principal residence.
The survey was implemented as part of the routinely
conducted health reporting activities of the Robert
Koch-Institute and fulfils all requirements and guidelines
of the Federal data protection act. Participation in the
survey was voluntary and anonymous and all partici-
pants provided informed consent before participation
[31]. The survey was approved by the Federal Commis-
sioner for Data Protection and Freedom of Information.
Following national guidelines for secondary data ana-
lyses, no further ethical approval was necessary for the
present analysis [32].
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Given that in Germany cervical cancer screening is
recommended for women 20 years of age or older, we
only included women of that age group in the analysis,
resulting in a sample size of n = 12,725.
Study variables
In the survey, women had been asked about the last time
they underwent a Pap smear, with the response categor-
ies being “within the last 12 months”, “1 to less than 2
years ago”, “2 to less than 3 years ago”, “3 years or more
ago” and “never”. For the present study, we applied a
conservative assessment of participation and distin-
guished between women who have participated at least
once in their life time and those who have never
participated.
We compared the participation in cervical cancer
screening between the three population groups of non-
migrants, migrants from EU countries and migrants
from non-EU countries. In line with the standardization
employed in the European Health Interview Survey, re-
spondents were regarded as migrants if they were either
born outside of Germany or have a non-German nation-
ality [33].
Based on the Andersen Model of Health Services Use
[30], we took different predisposing, enabling and need
factors as covariates into account. As predisposing fac-
tors, we considered, sex, age (five-year age groups treated
as a continuous measure), partnership status (living with
a partner vs. not living with a partner) and socioeconomic
status (SES) (low, middle and high). The SES was a stan-
dardized summary measure based on vocational educa-
tion, occupational status and net equivalent income [34].
As enabling factors, we considered the social support
(poor, moderate, strong) as measured by the Oslo-3 So-
cial Support Scale [35], place of residence (West
Germany, East Germany) and the type of residential area
(rural, small towns [5000–19,999 residents], medium-
sized towns [20,000–99,999 residents] and cities [> 99,
999 residents]) [36]. As need factors, we took into ac-
count the self-rated health status (based on a mean
score with responses ranging from 1 [“very good”] to 5
[“very poor”]) and the presence of chronic diseases (no,
yes). All variables included in the analysis had less than
2% of values missing.
Analysis
We used chi-square (χ2) tests and analysis of variance
for purposes of sample description where appropriate.
For all tests, the significance level was set to p < 0.05. To
examine differences in the utilization of cervical cancer
screening between the three population groups adjusted
for predisposing, enabling and need factors, we used a
multivariable logistic regression main effects model
reporting odds ratios (OR) and their 95%-confidence
intervals (95%-CI) as effects estimates. To examine the
moderating effects of these factors, in a subsequent step,
we included interaction terms between each of the fac-
tors and migration status into the model one-by-one
[37]. The evaluation of moderating effects was based on
average marginal effects (AME) given that ORs may be
biased by unobserved heterogeneity [38]. We conduced
all analyses using Stata 15 [39].
Results
Of the n = 12,725 women aged 20 and above, 12,064
provided information on all variables and were included
in further analysis. Of these, 4.1% were migrants from
EU countries and 4.1% were migrants from non-EU
countries. The population groups differed by some of
the predisposing, enabling and need factors (Tab. 1).
Particularly, non-EU migrants were younger, had a lower
socioeconomic status and perceived less often strong so-
cial support than non-migrants. Among both groups of
migrants, the percentage living with no partner, residing
in rural areas as well as in the Eastern part of Germany
was considerably lower than among non-migrants. In
terms of participation in cervical cancer screening, non-
EU and EU migrant women reported a significantly
lower utilization (50.1 and 52.7%, respectively) than non-
migrant women (57.2%).
These differences also remained evident after adjust-
ment for the role of predisposing, enabling and need fac-
tors. As the main effects logistic model (Tab. 2) shows,
non-EU and EU migrant women had 33 and 20%, re-
spectively, lower odds of participation in cancer screen-
ing than non-migrant women (OR = 0.67, 95%-CI =
0.55–0.81 and OR = 0.80, 95%-CI = 0.66–0.97,
respectively).
Except for the type of residential area, all of the predis-
posing, enabling and need factors studied were signifi-
cantly associated with utilization. A younger age, living
together with a partner, having a higher socioeconomic
status and higher social support were associated with
higher odds of participation in cervical cancer screening.
Similarly, women with chronic conditions were more
likely to have utilized screening at least once before the
survey. Conversely, higher age and worse self-perceived
health status were associated with lower odds of having
received a Pap smear before the survey.
An investigation of interaction effects revealed that
differences between migrants and non-migrants were
particularly pronounced for younger age groups which
decreased with age. Conversely, this means that age was
only a significant determinant of utilization for non-
migrants, with older women being at a lower likelihood
of participation in cancer screening (Fig. 1). Self-rated
health was associated with participation in screening
only in non-migrants, with a poorer health being
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indicative of a low participation in cancer screening
(Fig. 2). The role of other predisposing, enabling and
need factors did not significantly differ between the
three population groups.
Discussion
In many countries, migrants utilize cancer screening, in-
cluding cervical cancer screening, less frequently than
the majority population [13–17]. Findings from studies
in Germany are inconsistent with some reporting
disparities in favor of non-migrants [27] while others
observed a higher utilization among migrants [29]. Aside
from being restricted to some regions of Germany, a
major limitation of these studies is a potential bias
through residual confounding since only a limited num-
ber of influencing factors could be taken into account.
Using large and nationwide survey data, the present
study examined predisposing, enabling and need factors
for the utilization of cervical cancer screening in mi-
grants and non-migrants in Germany.









N 11,081 490 493
Age < 0.01
20–39 years 3346 (30.2%) 157 (32.0%) 225 (45.6%)
40–59 years 4501 (40.6%) 198 (40.4%) 180 (36.5%)
60 + years 3234 (29.2%) 135 (27.6%) 88 (17.8%)
Partnership status < 0.01
Partner 6239 (56.3%) 307 (62.7%) 306 (62.1%)
No partner 4842 (43.7%) 183 (37.3%) 187 (37.9%)
Socioeconomic status < 0.01
Low 1579 (14.2%) 74 (15.1%) 105 (21.3%)
Moderate 6622 (59.8%) 251 (51.2%) 252 (51.1%)
High 2880 (26.0%) 165 (33.7%) 136 (27.6%)
Social support < 0.01
Low 1709 (15.4%) 101 (20.6%) 118 (23.9%)
Moderate 5858 (52.9%) 256 (52.2%) 269 (54.6%)
High 3514 (31.7%) 133 (27.1%) 106 (21.5%)
Region < 0.01
Western Germany 8118 (73.3%) 436 (89.0%) 439 (89.0%)
Eastern Germany 2963 (26.7%) 54 (11.0%) 54 (11.0%)
Type of residential area < 0.01
Cities 3340 (30.1%) 205 (41.8%) 225 (45.6%)
Medium-sized towns 3872 (34.9%) 196 (40.0%) 201 (40.8%)
Small towns 1768 (16.0%) 54 (11.0%) 39 (7.9%)
Rural 2101 (19.0%) 35 (7.1%) 28 (5.7%)
Self-rated health status [1 “very good” to 5 “very poor”], mean
(SD)
2.2 (0.8) 2.1 (0.8) 2.2 (0.8) 0.04
Presence of chronic diseases 0.07
No 5881 (53.1%) 272 (55.5%) 285 (57.8%)
Yes 5200 (46.9%) 218 (44.5%) 208 (42.2%)
Utilization of cervical cancer screening < 0.01
Yes (at least once in life time) 6342 (57.2%) 258 (52.7%) 247 (50.1%)
No 4739 (42.8%) 232 (47.3%) 246 (49.9%)
* p-value from chi-square test for categorical variables and analysis of variance for continuous variables
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The study shows that EU- and non-EU migrant
women residing in Germany utilize cervical cancer
screening less often than non-migrant women. These
differences cannot be explained by a different distribu-
tion of predisposing, enabling and need factors between
the population groups as a multivariable analysis re-
vealed. The findings are in line with studies from other
countries [13–17]. They also suggest that additional fac-
tors need to be considered when addressing disparities
in the utilization of cervical cancer screening among mi-
grants. Similar to disparities in the utilization of other
health services, the lower average level of utilization
among migrant women is likely indicative of different
obstacles this population group encounters in the health
system. These barriers include a limited German lan-
guage proficiency, lack of information and low health lit-
eracy [40]. Furthermore, because of discrimination, lack
of awareness and/or insufficient financial resources,
health care providers often do not adequately meet the
(cultural) expectations migrants have towards health
care. These may, for example, comprise religious and
cultural taboos or disadvantageous beliefs about illness
and treatment [6, 21, 25, 41].
Aside from differences between migrants and non-
migrants, the study also identified different predisposing,
enabling and need factors relevant for the utilization of
cervical cancer screening among the population in
Germany. The findings are in line with research from
other countries [42–44]. In our study, women living in
the Eastern part of Germany had a higher likelihood of
cervical cancer screening use. This corresponds to find-
ings from studies based on routine data [45] and can be
explained by more thorough screening policies in the
former Democratic Republic of Germany before reunifi-
cation [46].
The study showed that most of the predisposing, enab-
ling and need factors did not significantly differ between
migrant and non-migrant women. Age was identified as
a moderating factor with disparities between migrant
and non-migrant women decreasing with age. Age has
also been identified as a moderator for disparities be-
tween migrants and non-migrants with respect to the
utilization of other health services such as regular dental
check-ups [47]. Because no information on the length of
stay was available in the data, it remains unclear whether
this finding is attributable to acculturation and increased
knowledge of the German health care system among
those with a longer length of stay [48]. Aside from age,
the effect of self-rated health also differed between mi-
grants and non-migrants. A significant association be-
tween self-rated health and utilization of cervical cancer
screening could only be observed for non-migrants.
Table 2 Results of the multivariable logistic regression model with utilization of cervical cancer screening as the dependent variable.
Odds ratios (OR) and 95% confidence intervals (95%-CI) (German Health Update 2014/2015, women age 20 years and above, n =
12,064; Main effects model. No interaction effects included)
Independent variable Odds Ratio 95%-CI p-value
Population group (Ref.: Non-migrants)
Migrants from EU countries 0.80 0.66; 0.97 0.02
Migrants from non-EU countries 0.67 0.55; 0.81 < 0.01
Age 0.86 0.85; 0.87 < 0.01
Partnership status (Ref.: No partner)
Partner 1.59 1.47;1.73 < 0.01
Socioeconomic status (Ref.: Low)
Moderate 1.49 1.33; 1.66 < 0.01
High 1.83 1.61;2.09 < 0.01
Social support (Ref.: Low)
Moderate 1.28 1.15; 1.42 < 0.01
High 1.46 1.30; 1.65 < 0.01
Region (Ref.: Western Germany)
Easters Germany 1.18 1.07; 1.30 < 0.01
Type of residential area (Ref.: Cities)
Medium-sized towns 0.95 0.86; 1.04 0.25
Small towns 1.04 0.92; 1.17 0.56
Rural 0.50 0.85; 1.08 0.50
Self-rated health status [1 “very good” to 5 “very poor”] 0.85 0.80; 0.90 < 0.01
Presence of chronic diseases (Ref.: No)
Yes 1.23 1.13; 1.35 < 0.01
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Fig. 2 Probability of the utilization of cervical cancer screening by population group and self-rated health status. Results of the multivariable
logistic regression model with utilization of cervical cancer screening as the dependent variable and interaction effects between self-rated health
and population group. (German Health Update 2014/2015, women age 20 years and above, n = 12,064; results from logistic regression model
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Fig. 1 Probability of the utilization of cervical cancer screening by population group and age. Results of the multivariable logistic regression
model with utilization of cervical cancer screening as the dependent variable and interaction effects between age and population group.
(German Health Update 2014/2015, women age 20 years and above, n = 12,064; results from logistic regression model with interaction effects
between age and migrant status)
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These differences could be explained by a possible at-
tenuation of the association through particular illness
beliefs such as fatalism, which have been shown to affect
the uptake of cancer screening and to be associated with
self-rated health [49, 50].
Strengths of the present study are the large and na-
tionwide sample as well as high quality of data collec-
tion. To the best of our knowledge, it is also the first
study applying the Andersen Model of Health Services
Use as a comprehensive theoretical framework to study
disparities in the utilization of cancer screening among
the migrant population in Germany. Some limitations
inherent to the data need to be considered as well. First,
the study was conducted in German language only. It is
therefore likely that migrants with limited German-
language proficiency are underrepresented. Since poor
German-language proficiency can be a significant barrier
with respect to the utilization of health services [25, 51],
it can be assumed that our study underestimates the dis-
parities in the utilization of cervical cancer screening
among migrants. Aside from language proficiency, we
were also not able to take into account heterogeneity
with respect to religion, culture, ethnicity, acculturation
and length of stay, which previous research has identi-
fied to also influence participation in cervical cancer
screening [14, 15, 52]. In order to devise more targeted
patient-oriented services, future studies need to examine
the role of these factors for migrants in Germany. Sec-
ond, all information, including data on the utilization of
cancer screening, were based no self-reports. Evidence
on the validity of self-reported utilization of cancer
screening is inconclusive [53, 54]. With respect to statu-
tory health checks in Germany, studies have shown that
self-reported information collected in the German
Health Update survey corresponds to administrative data
and can be considered valid [55]. Similarly, the self-
reported information on demographic and socioeco-
nomic factors can be considered valid given that the dis-
tribution of these factors in the sample resembles that of
the total population in Germany in the year the data was
collected [56].
Conclusion
This study was the first to investigate disparities in the
uptake of cervical cancer screening among migrant and
non-migrant women in Germany using nationwide data.
The lower utilization of migrant as compared to non-
migrant women can probably be explained by barriers
migrants encounter in health care indicating that the
health system is not sufficiently sensitive to the needs
and expectations of this population group. Implementing
patient-oriented health care through diversity-sensitive
health services is necessary to supported informed deci-
sion making. This does not only include information
taking into account the oftentimes limited health literacy
of this population group, but also comprises information
and services which consider their cultural needs and
expectations.
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